MATERIAL SAFETY DATA SHEET AMPICILLIN, SODIUM SALT I IDENTIFICATION: V FIRE AND EXPLOSION HAZARDS: BioShop Canada Inc. Flammable: No 4060 Fairview St Unit #6-8 Flash Point: N/A Burlington, OntarioL7L 4Y8 Extinguishing Media: Water, dry chemical, chemical foam or alcohol 1-800-234-1179
resistant foam. Explosion Data: Not available Emergency Telephone No.: 905-466-3832 VI REACTIVITY: Chemical Name: Ampicillin sodium salt Catalog Number: AMP201 Stability: Stable under normal temperatures and pressure Molecular Formula: C16H18N3O4SNa Conditions to avoid; dust generation Molecular Weight: 371.19 Incompatibility: strong oxidizing reagents WHMIS Classification: D2A, D2B Hazardous Decomposition Products: carbon monoxide, carbon dioxide, TSCA Status: not listed on the TSCA Inventory
nitrogen oxides, oxides of sulfur Hazardous Polymerization: Will not occur II HAZARDOUS INGREDIENTS: VII PHYSICAL DATA: CAS # RTECS # % Physical State: Solid Ampicillin sodium Appearance and Odor: white to off-white, odorless Melting Point: 419° F Boiling Point: n/a Specific Gravity: n/a III HAZARDS/TOXICOLOGICAL PROPERTIES: Vapor Density: Solubility: Soluble in water Potential Health Effects: May be harmful if swallowed. May cause eye and skin irritation. May cause allergic reactions VIII PREVENTIVE MEASURES: Target Organs: Eyes, skin respiratory system Eyes: Causes eye irritation. Skin: Causes skin irritation. Personal Protection: Wear appropriate protective gloves and clothes to Inhalation: May be harmful if swallowed. May cause irritation. May cause
nausea, vomiting. May cause allergic reaction causing anaphylactic shock
Ventilation: Local exhaust systems. Ingestion: Causes irritation. May cause allergic reaction. Respiratory protection: Use NIOSH/MSHA approved full face-piece CHRONIC HEALTH HAZARDS: No information.
respirator. Leak and Spill Procedures: Wear appropriate protective equipment. Exposure Limits:
Sweep up then place into a suitable container for disposal. Waste Disposal: Follow local disposal regulations. Storage Conditions: Store in a cool, dry place. Store in a tightly closed container. Label Hazard Warning: Irritating to eyes, respiratory system and skin. Shipping Information: Not regulated IX PREPARATION OF MSDS: Epidemiology: No data available Teratogenicity; No data available Reproductive Effects: No data available Neurotoxicity: No data available Mutagenicity: No data available Carcinogenicity: Not listed by ACGIH, IARC, NTP, or OSHA
The information provided on this Material Safety Data Sheet is furnished in good faith and without warranty of any kind. The above information is
IV FIRST AID MEASURES:
believed to be correct and should be used only as a guide. BioShop CanadaInc. shall not be held liable for any damage resulting from the handling or
Eyes: Flush eyes with plenty of water for at least 15 minutes.
from the contact with the above product. Skin: Flush area immediately with plenty of soap and water while removing contaminated clothing and shoes.
Observe all federal, provincial and state laws concerning health,
Inhalation: Remove victim to fresh air. If not breathing give
artificial respiration. If breathing is difficult give oxygen and GET MEDICAL ATTENTION. Ingestion: Wash mouth with water. DO NOT INDUCE VOMITING.GET MEDICAL ATTENTION.
Digestive Disease Consultants Purchase these items ahead of time: 1. Four Dulcolax tablets (stool softeners or laxative) 2. One bottle of Miralax (230/238) Gram 3. Two 32-ounce bottles of Gatorade (no red colors), preferably clear 4. Tuck’s pads, Vaseline, Desitin etc can be used to protect the anal area if needed Colonoscopy Preparation Timeline Five or mor
SUMMARY OF THE PRODUCT CHARACTERISTICS NAME OF THE MEDICINAL PRODUCT Novastan 100 mg/ml concentrate for solution for infusion. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml concentrate for solution for infusion contains 100 mg argatroban. 1 Vial with 2.5 ml concentrate for solution for infusion contains 250 mg argatroban. Final concentration after dilution as recommended is 1 mg/ml